Mortara, Umberto
Orlando, Giulia
Volante, Marco
Papotti, Mauro
Duregon, Eleonora
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 27891)
Article History
Accepted: 27 May 2025
First Online: 4 June 2025
Declarations
:
: Not applicable.
: All authors consent to publication.
: MP and MV are Editorial Board members of Endocrine Pathology. Other disclosures for MP include honoraria from Lilly, AstraZeneca and AbbVie in past two years, for educational projects not connected with the topic of this review article. All other authors have nothing to disclose.